Early Management of Metabolic Syndrome and Improvement of Cardiometabolic and Pulmonary Function for the Establishment of Omics-Based Multi-Biomarker Precision Nutrition

Beneficial effect of early control of metabolic syndrome risk on cardio-metabolic and lung function using omics based multi-biomarker panel: establishment of precision nutrition for sustainable healthy life

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011702

Enrollment

Registered

2026-03-10

Start date

2024-12-13

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Personalized Dietary and lifestyle intervention) : - Participants(19 -64 years old) who are overweight or have at least one risk factor for metabolic syndrome will receive personalized dietary

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: · Participants will be selected among adult men and women aged 19–64 years who meet at least one of the following criteria at the screening visit: ? Overweight or obesity: body mass index (BMI) = 23 kg/m² (based on the criteria of the Korean Society for the Study of Obesity) ? Presence of at least one metabolic syndrome risk factor [Metabolic syndrome risk factors] (1) Fasting glucose = 100 mg/dL or current use of glucose-lowering medication (2) Waist circumference = 90 cm in men or = 85 cm in women (3) Blood pressure: systolic = 130 mmHg or diastolic = 85 mmHg, or current use of antihypertensive medication (4) Triglycerides = 150 mg/dL at recent health examination or current use of lipid-lowering medication (5) HDL-cholesterol: < 40 mg/dL in men or < 50 mg/dL in women at recent health examination, or current use of lipid-lowering medication

Exclusion criteria

Exclusion criteria: · Individuals with diagnosed chronic diseases requiring ongoing treatment, such as coronary artery disease, stroke, liver disease, cancer, or other serious conditions · Individuals with a history within the past 3 months of surgery (including ophthalmic, open-heart, or abdominal surgery), myocardial infarction, cardiac arrest, pneumothorax, retinal detachment, or aortic aneurysm · Pregnant or lactating women, or any individual judged by the investigator to be inappropriate for participation in this study

Design outcomes

Primary

Measure	Time frame
Metabolic syndrome risk factors (waist circumference, blood pressure, fasting glucose, HDL-cholesterol, triglycerides, or body mass index [BMI])	—

Secondary

Measure	Time frame
oxidative stress;pulmonary function ;adipomyokine;microbiome;genetic polymorphisms	—

Countries

Korea, Republic of

Contacts

Public ContactOh Yoen Kim

Dong-A University

oykim@dau.ac.kr+82-51-200-7326

Outcome results